Based on these factors, China's COVID-19 Suggestions for Glucocorticoid Use [16] clearly indicate that in patients with diabetes receiving oral hypoglycemic agents or insulin treatment, glucocorticoid use should be carefully considered when treating COVID-19. This evidence concerns the gene INS and diabetes mellitus.